|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/404 | |
| A61K 45/06 | |||
| C07D 405/04 |
| (11) | Number of the document | 3087068 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14875724.8 |
| Date of filing the European patent application | 2014-10-29 | |
| (97) | Date of publication of the European application | 2016-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2014/050936 |
| Date | 2014-10-29 |
| (87) | Number | WO 2015/097691 |
| Date | 2015-07-02 |
| (30) | Number | Date | Country code |
| 201361964168 P | 2013-12-26 | US |
| (72) |
LEIBA, Merav, IL
ROZIC, Gabriela, IL
|
| (73) |
Tel HaShomer Medical Research Infrastructure and Services Ltd.,
The Chaim Sheba Medical Center Tel HaShomer, 5262000 Ramat Gan,
IL
|
| (54) | STK 405759 FOR THE TREATMENT OF MULTIPLE MYELOMA OR MYELOFIBROSIS |
| STK 405759 FOR THE TREATMENT OF MULTIPLE MYELOMA OR MYELOFIBROSIS |